269 related articles for article (PubMed ID: 24874977)
1. Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.
Dormuth CR; Filion KB; Paterson JM; James MT; Teare GF; Raymond CB; Rahme E; Tamim H; Lipscombe L;
BMJ; 2014 May; 348():g3244. PubMed ID: 24874977
[TBL] [Abstract][Full Text] [Related]
2. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
[TBL] [Abstract][Full Text] [Related]
3. Statin potency and the risk of hospitalization for community-acquired pneumonia.
Shin JY; Eberg M; Ernst P; Filion KB
Br J Clin Pharmacol; 2017 Jun; 83(6):1319-1327. PubMed ID: 27943383
[TBL] [Abstract][Full Text] [Related]
4. Risk of incident diabetes among patients treated with statins: population based study.
Carter AA; Gomes T; Camacho X; Juurlink DN; Shah BR; Mamdani MM
BMJ; 2013 May; 346():f2610. PubMed ID: 23704171
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
[TBL] [Abstract][Full Text] [Related]
6. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
7. Risk of new-onset diabetes mellitus during treatment with low-dose statins in Japan: A retrospective cohort study.
Kato S; Miura M
J Clin Pharm Ther; 2018 Aug; 43(4):536-542. PubMed ID: 29484697
[TBL] [Abstract][Full Text] [Related]
8. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.
Anyanwagu U; Mamza J; Donnelly R; Idris I
Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.
Ooba N; Setoguchi S; Sato T; Kubota K
BMJ Open; 2017 Jun; 7(6):e015935. PubMed ID: 28667223
[TBL] [Abstract][Full Text] [Related]
10. New-Onset Diabetes After Statin Exposure in Elderly Women: The Australian Longitudinal Study on Women's Health.
Jones M; Tett S; Peeters GM; Mishra GD; Dobson A
Drugs Aging; 2017 Mar; 34(3):203-209. PubMed ID: 28138911
[TBL] [Abstract][Full Text] [Related]
11. Statins, risk of diabetes, and implications on outcomes in the general population.
Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
[TBL] [Abstract][Full Text] [Related]
12. Statins and risk of treated incident diabetes in a primary care population.
Zaharan NL; Williams D; Bennett K
Br J Clin Pharmacol; 2013 Apr; 75(4):1118-24. PubMed ID: 22845189
[TBL] [Abstract][Full Text] [Related]
13. Association of statins with diabetes mellitus and diabetic complications: role of confounders during follow-up.
Mansi IA; Frei CR; Halm EA; Mortensen EM
J Investig Med; 2017 Jan; 65(1):32-42. PubMed ID: 27574296
[TBL] [Abstract][Full Text] [Related]
14. Comparison between high and low potency statins in the incidence of open-angle glaucoma: A retrospective cohort study in Japanese working-age population.
Ooba N; Iwahashi R; Nogami A; Nakayama T; Kanno A; Tochikura N; Ootsuka S; Fukuoka N
PLoS One; 2020; 15(8):e0237617. PubMed ID: 32804969
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.
Lin TK; Chou P; Lin CH; Hung YJ; Jong GP
PLoS One; 2018; 13(5):e0196713. PubMed ID: 29723231
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy prevents the onset of Parkinson disease in patients with diabetes.
Lin KD; Yang CY; Lee MY; Ho SC; Liu CK; Shin SJ
Ann Neurol; 2016 Oct; 80(4):532-40. PubMed ID: 27471847
[TBL] [Abstract][Full Text] [Related]
17. The effect of statins on influenza-like illness morbidity and mortality.
Brassard P; Wu JW; Ernst P; Dell'Aniello S; Smiechowski B; Suissa S
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):63-70. PubMed ID: 27686457
[TBL] [Abstract][Full Text] [Related]
18. Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults.
Mansi I; Frei CR; Wang CP; Mortensen EM
J Gen Intern Med; 2015 Nov; 30(11):1599-610. PubMed ID: 25917657
[TBL] [Abstract][Full Text] [Related]
19. High-potency statins increase the risk of acute kidney injury: evidence from a large population-based study.
Corrao G; Soranna D; Casula M; Merlino L; Porcellini MG; Catapano AL
Atherosclerosis; 2014 May; 234(1):224-9. PubMed ID: 24681912
[TBL] [Abstract][Full Text] [Related]
20. Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real-world evidence from Italy.
Corrao G; Monzio Compagnoni M; Cantarutti A; Rea F; Merlino L; Catapano AL; Mancia G
Diabetes Res Clin Pract; 2020 Jun; 164():108197. PubMed ID: 32389742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
